Thierry Bourguignon
Prof Thierry Bourguignon is an expert in Cardiology at Centre Hospitalier Universitaire de Tours (France). Thierry Bourguignon has authored 110 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 2 of them ongoing. SLR score: 355 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Thoracic And Cardiovascular Surgery - Surgery - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2011 - 2026
Number : 110
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Bioprosthetic aortic valve replacement in patients under 60 years - 3-year safety results from the indure registry. PMID 42523170 — registries, mortality, safety, aortic valve | Interdiscip Cardiovasc Thorac Surg | 2026 | 0 |
| P2X4 receptor limits adverse cardiac remodeling following ischemia-reperfusion through regulation of autophagy in cardiac fibroblasts. PMID 42426875 — autophagy, myofibroblasts, fibrosis, receptors, purinergic p2x4, reperfusion, cell communication, ligation, fibroblasts, tissues, ischemia | Cell Commun Signal | 2026 | 0 |
| Valve-sparing aortic root replacement: Defining high-volume centres using prospective data. PMID 42178209 — thoracic surgery, aortic valve | Eur J Cardiothorac Surg | 2026 | 0 |
| Impact of surgical timing on outcomes after transcatheter aortic valve explantation: insights from a French multicenter retrospective study. PMID 42057182 — mortality, retrospective studies, aortic valve, transcatheter aortic valve replacement | J Cardiothorac Surg | 2026 | 0 |
| Redo versus first transcatheter aortic valve implantation: A propensity score-matched analysis. PMID 41698771 — confidence intervals, hemorrhage, hospitalization, ischemic stroke, stroke, heart failure, heart, cardiovascular diseases, propensity score, aortic valve, transcatheter aortic valve replacement | Arch Cardiovasc Dis | 2026 | 0 |
Clinical Studies 5
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation APOLLO EU Trial NCT05496998 — lymphoma, follicular, constriction, pathologic, mitral valve, lymphoma, therapeutics, mitral valve stenosis, gastroesophageal reflux, mitral valve insufficiency, transcatheter mitral valve replacement | N/A | Recruiting | 2023 |
| LVAD Versus GDMT in Ambulatory Advanced Heart Failure Patients NCT04768322 — enzyme inhibitors, sodium-glucose transporter 2 inhibitors, angiotensin ii, receptors, angiotensin, angiotensin-converting enzyme inhibitors, heart failure, heart, symporters, peptidyl-dipeptidase a, signs and symptoms, neprilysin, receptors, mineralocorticoid, angiotensins, enzymes, heart failure, systolic, maximum tolerated dose, therapeutics, mineralocorticoids, random allocation, mineralocorticoid receptor antagonists | N/A | Recruiting | 2021 |
LeadR Networks
Main global connection map